Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-691-2 | CAS number: 13465-08-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
An acute oral LD50 of 300 - 400 mg/kg bw in rats was determined for hydroxylammonium sulphate. The studies all indicate that animals displayed cyanosis and methaemoglobinaemia. No data on the acute inhalation toxicity of hydroxylammonium nitrate or analogues were located. An acute dermal LD50 of 70 mg/kg bw was identified for hydroxylammonium nitrate in rabbits. An acute dermal LOAEL of 10 mg/kg bw of hydroxylammonium sulphate was determined in the rat and rabbit based on methaemoglobinaemia.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1950
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study conducted prior to establishment of standardised guidelines, also unclear calculations of LD50
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- White mice (10/sex/dose) were orally administered hydroxylammonium hydrochloride and observed for 72 hours. No further details reported.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- mouse
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- No data.
- Route of administration:
- oral: unspecified
- Vehicle:
- water
- Details on oral exposure:
- Hydoxylammonium hydrochloride was given in 0.5 - 2 % aqueous solution so that the amount of liquid introduced for all the mice lay between 0.3 and 0.5 ml.
- Doses:
- 200, 300, 400, 500 and 600 mg/kg.
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 72 hours.
- Frequency of observations and weighing: Not stated.
- Necropsy of survivors performed: Not stated. - Statistics:
- Not stated
- Sex:
- female
- Dose descriptor:
- approximate LD50
- Effect level:
- ca. 419 other: mg/kg
- Based on:
- dissolved
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- ca. 408 other: mg/kg
- Based on:
- dissolved
- Mortality:
- See table.
- Clinical signs:
- Not stated.
- Body weight:
- Not stated.
- Gross pathology:
- Methaemoglobin was observed in the dead animals.
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- The calculated LD50s are not reflective of the mortality observed in the study. The authors calculated an LD50 for male and female mice of 408 and 419 mg/kg. However from the mortality reported, the true LD50 should lie between the doses of 300 and 400 mg/kg for both male and female mice.
- Executive summary:
In an acute oral toxicity study, groups of white mice (10/sex/dose) were given a single oral dose of hydroxlammonium hydrochloride at doses of 200, 300, 400, 500 and 600 mg/kg bw and observed for 72 hours. The authors calculated an LD50 for male and female mice of 408 and 419 mg/kg bw. However, the calculated LD50 is not reflective of the actual mortality reported in the study. The LD50 for both male and female mice was determined to be between 300 - 500 mg/kg bw. This reliability of this study is considered to be reliable with restrictions as the study was conducted prior to the establishment of standardised guidelines, however the calculated LD50s should be interpreted with caution.
Reference
Mortality of animals from the administration of different doses of hydroxylammonium hydrochloride.
Dose (mg/kg) |
Mortality (male) |
Mortality (female) |
200 |
0/10 |
0/10 |
300 |
3/10 |
4/10 |
400 |
7/10 |
6/10 |
500 |
9/10 |
6/10 |
600 |
10/10 |
10/10 |
Calculated LD50 (mg/kg) |
408 |
419 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 300 mg/kg bw
- Quality of whole database:
- Studies were conducted prior to the establishment of guidelines or standardised methods, however they were reported in sufficient detail to identify an LD50.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1980-1982
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No details on study method or GLP status are available in the study report.
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- No data provided.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rabbit
- Type of coverage:
- open
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 70 mg/kg bw
- Interpretation of results:
- Toxicity Category III
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Hydroxylammonium nitrate is acutely toxic via the dermal route, with and LD50 of 70 mg/kg bw identified in rabbits.
- Executive summary:
Hydroxylammonium nitrate is acutely toxic via the dermal route, with and LD50 of 70 mg/kg bw identified in rabbits.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 70 mg/kg bw
- Quality of whole database:
- Studies did not follow standardised guidelines, however they were well reported. Three studies did not use doses that were sufficient to determine an LD50.
Additional information
The acute oral toxicity of hydroxylammonium hydrochloride was determined to be between 300 - 400 mg/kg bw in rats. This chemical is considered to be a suitable analogue for hydroxylammonium nitrate, therefore read-across of data has been used. Of the two other acute oral studies located, one study identified a lower LD50 in cats, however the test species was a none-standardised species in acute toxicity testing, furthermore cats have been associated with greater formation of methaemoglobin indicating that they are potentially a more sensitive test species. This value indicates that classification with Acute Tox 4 (LD50 50 -300 mg/kg bw).
An acute dermal LD50 of 70 mg/kg bw was identified for hydroxylammonium nitrate in rabbits. An acute dermal LOAEL of 10 mg/kg bw of hydroxylammonium sulphate was determined in the rat and rabbit based on methaemoglobinaemia.
One study implied that the acute dermal toxicity of hydroxylammonium sulphate was dependent upon the nature of the exposure. The test chemical evidently had greater toxicity when applied under an occlusive patch compared to semi-occlusive, although the authors do not explain the observation. Of the four dermal toxicity studies, three reported adverse effects including skin irritation and haemorrhagic necrosis in rats and rabbits. A dermal LOAEL of 10 mg/kg bw was determined in both the rat and rabbit based on methaemoglobinaemia, rats also displayed splenomegaly at this dose, in another study at 1500 mg/kg, alteration in the gross pathology of rabbits were observed although no methaemoglobinaemia was observed. One study in rabbits (400 mg/kg bw 50% aqueous solution, occlusive, 24 hours) reported no adverse effects, however as the weight of evidence and existing classification of irritation and toxicity of hydroxylammonium sulphate exist this study was disregarded.
The toxicity observed after the oral and dermal administration of hydroxylammonium nitrate and its analogues were similar to effects observed after acute administration via intraperitoneal administration in rats.
Justification for selection of acute toxicity – oral endpoint
Of the studies located, this was considered the most reliable in terms of study design and data reporting. The other studies available were either in cats (which although more prone to methaemoglobinaemia and therefore potentially a more sensitive species) are a non-regulatory species for acute toxicity testing or had a higher LD50. The calculated LD50 for hydroxylammonium hydrochloride in this study was not consistent with the data reported, however using the raw data and LD50 of between 300- 400 mg/kg bw can be determined.
Justification for selection of acute toxicity – dermal endpoint
This study was performed on the test substance itself.
Justification for classification or non-classification
Hydroxylammonium nitrate has a harmonised classification of Acute Tox 4*, Harmful if swallowed and Acute Tox 3*, Toxic in contact with skin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.